Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
about
Gene therapy for lower urinary tract dysfunctionStem cells for urinary tract regenerationStem cell therapy in bladder dysfunction: where are we? And where do we have to go?Stem Cells: It's Good To Have Choices.Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells.Stem cells for the treatment of urinary incontinence.Stem cell transplantation for treating Duchenne muscular dystrophy: A Web of Science-based literature analysisMuscle-derived stem cells for tissue engineering and regenerative therapy.Basal Lamina Mimetic Nanofibrous Peptide Networks for Skeletal Myogenesis.Diagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity.Muscling in on stem cells.Coining a new term-Urovesicology: advancing towards a mechanistic understanding of bladder symptoms.Gene therapy used for tissue engineering applications.Sphincter contractility after muscle-derived stem cells autograft into the cryoinjured anal sphincters of ratsStem and endothelial progenitor cells in erection biology.Bioengineered tissues for urogenital repair in children.The clinical relevance of cell-based therapy for the treatment of stress urinary incontinence.Regeneration of skeletal muscle.Advanced therapeutic directions to treat the underactive bladder.Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence.Addressing challenges in underactive bladder: recommendations and insights from the Congress on Underactive Bladder (CURE-UAB).A tissue-engineered suburethral sling in an animal model of stress urinary incontinence.Intradetrusor injection of adult muscle-derived cells for the treatment of underactive bladder: pilot study.A novel method for differentiation of human mesenchymal stem cells into smooth muscle-like cells on clinically deliverable thermally induced phase separation microspheres.Dynamics of acute local inflammatory response after autologous transplantation of muscle-derived cells into the skeletal muscle.Pharmacological treatments available for the management of underactive bladder in neurological conditions.The potential of muscle-derived stem cells for stress urinary incontinence.Protective effect of sodium ascorbate on efficacy of intramuscular transplantation of autologous muscle-derived cells.Improvement of urethral sphincter deficiency in female rats following autologous skeletal muscle myoblasts grafting.Chitosan-gelatin sheets as scaffolds for muscle tissue engineering.Recent advances in the understanding and management of underactive bladder.
P2860
Q26824783-F4FFE394-F647-4030-AE4E-F21FFB9BFE97Q26830507-EE0AE610-73E8-443A-AF7F-704FE5B354A2Q26862700-9F21ACED-C02C-49FF-A8FE-E580497212D2Q33572568-8E95C339-A155-4B6D-B935-5B0F60E2838BQ34479398-C9652C38-AA40-4A44-802B-5612F34E1A02Q34491806-1C411ECB-891B-450A-A19C-DAE6F6B56B36Q34997665-36692AB6-02C0-4C8B-B4A6-66B82EA66331Q36171454-E4D86279-F389-4C86-AAC5-A1436F746A0AQ36265728-F78AA7EE-4F4F-4ED7-8709-A61B5D84AC2AQ36395035-A53434E7-C694-451C-A3BA-B594551F2E09Q36424273-EBEBE8A6-2BD5-4966-98BB-814C97C13945Q36463541-533CCEEA-6ED3-4239-B1AB-09FB2985D575Q36748645-E0423227-AA7D-4290-A86C-CE3AB1999976Q36839060-A76531BF-99DC-4219-9BBF-EB563181E49CQ37078842-CE4EE092-1EFF-43FF-BA08-3FDC66DD07EDQ37143948-38FF94EC-23A6-4AC7-9BE9-7E89A449228CQ37874640-9F5E2CB6-4884-4D13-839A-F551C9225AA0Q37888538-5F3C3B81-05A0-435B-94CA-F9318CAA2CDFQ38252669-251377D0-FA8B-4398-B38B-28A160AC914CQ38475944-E3617CE5-7B91-48BA-BDF7-A625ADE6A2DCQ39148756-EC49D1C1-D531-42B0-9975-5E45DC36E4B2Q40396566-2A2260CA-FBC8-430C-A659-4591ED625E96Q41495249-2814786D-067C-4457-A7F5-3531D7644F51Q41833608-B481ACC5-4AFC-440E-8676-B070952126D7Q42876335-AA252C00-A0EC-482C-98BD-30D51141511EQ47802223-2B0D4E4A-9A13-4C8E-BDDF-98ECAD3FBCADQ48557639-91719ECA-77EA-4917-8852-7414D6F68A9AQ50505656-BAFC4A7D-5F6D-400C-B22C-3435947D8C50Q51727741-283C142D-6B22-42DF-AE56-758506DCFED0Q53676677-4C1E6E52-F753-4CE8-AF4C-C11DEFAA55A5Q55259311-75C0ACD2-A76F-400F-A140-D39BF0A0CBD7
P2860
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
@en
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
@nl
type
label
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
@en
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
@nl
prefLabel
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
@en
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
@nl
P2093
P2860
P356
P1433
P1476
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.
@en
P2093
Chancellor MB
Pruchnic R
Somogyi GT
Yokoyama T
de Groat WC
P2860
P2888
P304
P356
10.1038/SJ.GT.3301816
P577
2002-12-01T00:00:00Z
P5875
P6179
1045179605